{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T05:59:54Z","timestamp":1780898394399,"version":"3.54.1"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"\n Background<\/jats:title>\n \n LncRNAs emerge as critical regulators of gene expression and epigenetic modulation in human cancer. However, the biological and clinical significance of the lncRNA\n GAS8-AS1<\/jats:italic>\n in differentiated thyroid cancers (DTCs) remains poorly understood.\n <\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n GAS8-AS1<\/jats:italic>\n expression in normal tissues was evaluated using LncExpDB. Quantitative RT-PCR was performed on 21 DTCs with matched adjacent normal tissues. RNA-seq data from TCGA (507 DTCs) were analyzed to assess\n GAS8-AS1<\/jats:italic>\n expression and clinicopathological associations. Independent validation was conducted using ENCORI (510 thyroid cancer, 58 normal) and TNMplot datasets. Expression profiles of\n GAS8-AS1<\/jats:italic>\n -associated genes were analyzed in TCGA and were corroborated with ENCORI dataset. Co-expression analyses were performed to identify regulatory relationships. Functional characterization was conducted using siRNA-mediated knockdown of\n GAS8-AS1<\/jats:italic>\n in HEK293T and BCPAP cells, and overexpression studies in papillary thyroid cancer cell lines (K1 and BCPAP). Cell proliferation, migration, and invasion assays were performed. Pathway enrichment analyses were used to identify\n GAS8-AS1<\/jats:italic>\n -mediated biological processes.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n GAS8-AS1<\/jats:italic>\n expression was significantly downregulated in DTCs compared with matched normal tissues (\n p<\/jats:italic>\n &lt; 0.0001). TCGA analysis confirmed lower\n GAS8-AS1<\/jats:italic>\n expression, which was markedly associated with early-stage disease (\n p<\/jats:italic>\n = 0.03) and lymph node metastasis (\n p<\/jats:italic>\n = 0.03).\n GAS8-AS1<\/jats:italic>\n downregulation was remarkably consistent in thyroid cancer (ENCORI,\n p<\/jats:italic>\n = 0.004). A dramatic downregulation of\n GAS8-AS1<\/jats:italic>\n was also observed across pan-cancer, including thyroid cancer (TNMplot,\n p<\/jats:italic>\n = 2.01 \u00d7 10\n -128<\/jats:sup>\n ). Expression analysis of\n GAS8-AS1<\/jats:italic>\n -associated genes revealed frequent deregulation in DTCs (24%), including downregulation of\n ATF2, ATG5, ATG7<\/jats:italic>\n , and\n BECN1<\/jats:italic>\n , and upregulation of\n NEAT1<\/jats:italic>\n and\n UCA1<\/jats:italic>\n . Co-expression analysis revealed that\n GAS8-AS1<\/jats:italic>\n and\n ATG5<\/jats:italic>\n expression levels were positively correlated with\n ATF2<\/jats:italic>\n , whereas\n NEAT1<\/jats:italic>\n showed a negative association, suggesting\n ATF2<\/jats:italic>\n -dependent transcriptional regulation of\n GAS8-AS1<\/jats:italic>\n ,\n ATG5<\/jats:italic>\n , and\n NEAT1<\/jats:italic>\n . Functional characterizations demonstrated that\n GAS8-AS1<\/jats:italic>\n knockdown significantly increased proliferation, migration, and invasion, whereas\n GAS8-AS1<\/jats:italic>\n overexpression markedly suppressed tumor cell proliferation. Pathway enrichment analyses implicated\n GAS8-AS1<\/jats:italic>\n -related genes in autophagy, apoptosis, proliferation, invasion, and metastasis.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n \n These findings demonstrate that\n GAS8-AS1<\/jats:italic>\n may function as a tumor suppressor in DTCs, with its downregulation associated with disease progression and metastasis. The consistent loss of\n GAS8-AS1<\/jats:italic>\n expression and its functional impact on tumor progression suggest that it may serve as a valuable diagnostic and prognostic biomarker in DTCs.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fendo.2026.1839154","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T05:36:03Z","timestamp":1780896963000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["LncRNA GAS8-AS1 is downregulated, correlates with early-stage disease and lymph node metastasis, and its knockdown promotes proliferation, migration, and invasion in differentiated thyroid cancer"],"prefix":"10.3389","volume":"17","author":[{"given":"Avaniyapuram Kannan","family":"Murugan","sequence":"first","affiliation":[{"name":"Division of Molecular Endocrinology, Department of Molecular Oncology, King Faisal Specialist Hospital and Research Centre","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hindi","family":"Al-Hindi","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Centre","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali S.","family":"Alzahrani","sequence":"additional","affiliation":[{"name":"Division of Molecular Endocrinology, Department of Molecular Oncology, King Faisal Specialist Hospital and Research Centre","place":["Riyadh, Saudi Arabia"]},{"name":"Department of Medicine, King Faisal Specialist Hospital and Research Centre","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/965212","article-title":"Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors","volume":"2013","author":"Pellegriti","year":"2013","journal-title":"J Cancer Epidemiol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2021.4804","article-title":"Evaluation of gender inequity in thyroid cancer diagnosis: differences by sex in US thyroid cancer incidence compared with a meta-analysis of subclinical thyroid cancer rates at autopsy","volume":"181","author":"LeClair","year":"2021","journal-title":"JAMA Intern Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12112716","article-title":"Patterns of thyroid cancer mortality and incidence in Saudi Arabia: a 30-year study","volume":"12","author":"Flemban","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3892\/ol.2025.15266","article-title":"Thyroid cancer: from molecular insights to therapy (review)","volume":"30","author":"Li","year":"2025","journal-title":"Oncol Lett"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0733-1","article-title":"The treatment of advanced thyroid cancer in the age of novel targeted therapies","volume":"77","author":"Lirov","year":"2017","journal-title":"Drugs"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3431","article-title":"Molecular pathogenesis and mechanisms of thyroid cancer","volume":"13","author":"Xing","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12967-016-0958-x","article-title":"Classical V600E and other non-hotspot BRAF mutations in adult differentiated thyroid cancer","volume":"14","author":"Murugan","year":"2016","journal-title":"J Transl Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(90)90659-3","article-title":"PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas","volume":"60","author":"Grieco","year":"1990","journal-title":"Cell"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021907","article-title":"RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma","volume":"88","author":"Nikiforova","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-13-0210","article-title":"Highly prevalent TERT promoter mutations in aggressive thyroid cancers","volume":"20","author":"Liu","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s12022-011-9155-x","article-title":"Uncommon GNAQ, MMP8, AKT3, EGFR, and PIK3R1 mutations in thyroid cancers","volume":"22","author":"Murugan","year":"2011","journal-title":"Endocr Pathol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated genomic characterization of papillary thyroid carcinoma","volume":"159","author":"Agrawal","year":"2014","journal-title":"Cell"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.26993","article-title":"GPCR-mediated PI3K pathway mutations in pediatric and adult thyroid cancer","volume":"10","author":"Murugan","year":"2019","journal-title":"Oncotarget"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1172\/JCI85271","article-title":"Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers","volume":"126","author":"Landa","year":"2016","journal-title":"J Clin Invest"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-4041","article-title":"Anaplastic thyroid cancers harbor novel oncogenic mutations of the ALK gene","volume":"71","author":"Murugan","year":"2011","journal-title":"Cancer Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-019-0787-5","article-title":"Identification and characterization of two novel oncogenic mTOR mutations","volume":"38","author":"Murugan","year":"2019","journal-title":"Oncogene"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113826","article-title":"The genomic and evolutionary landscapes of anaplastic thyroid carcinoma","volume":"43","author":"Zeng","year":"2024","journal-title":"Cell Rep"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.251547398","article-title":"Gene expression in papillary thyroid carcinoma reveals highly consistent profiles","volume":"98","author":"Huang","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12129","article-title":"TWIST1\/miR-584\/TUSC2 pathway induces resistance to apoptosis in thyroid cancer cells","volume":"7","author":"Orlandella","year":"2016","journal-title":"Oncotarget"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.718578","article-title":"Crosstalk between abnormal TSHR signaling activation and PTEN\/PI3K in the dedifferentiation of thyroid cancer cells","volume":"11","author":"Feng","year":"2021","journal-title":"Front Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12123657","article-title":"Non-coding RNAs as mediators of epigenetic changes in Malignancies","volume":"12","author":"Kumar","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3892\/or.2016.5236","article-title":"Non-coding RNAs as regulators in epigenetics (review)","volume":"37","author":"Wei","year":"2017","journal-title":"Oncol Rep"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.25269","article-title":"MicroRNAs: modulators of the Ras oncogenes in oral cancer","volume":"231","author":"Murugan","year":"2016","journal-title":"J Cell Physiol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-022-00566-8","article-title":"Long non-coding RNAs: definitions, functions, challenges and recommendations","volume":"24","author":"Mattick","year":"2023","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-17-0188","article-title":"Long noncoding RNAs: emerging players in thyroid cancer pathogenesis","volume":"25","author":"Murugan","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddw056","article-title":"Whole exome sequencing identifies lncRNA GAS8-AS1 and LPAR4 as novel papillary thyroid carcinoma driver alternations","volume":"25","author":"Pan","year":"2016","journal-title":"Hum Mol Genet"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-024-03802-7","article-title":"LncRNA GAS8-AS1 dinucleotide genetic variantn.713A>G, n.714T>C is associated with early-stage disease, lymph node, and distant metastasis in differentiated thyroid cancer","volume":"85","author":"Murugan","year":"2024","journal-title":"Endocrine"},{"key":"B28","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1615\/CritRevEukaryotGeneExpr.2022039770","article-title":"LncRNA GAS8-AS1 is a novel prognostic and diagnostic biomarker for pancreatic cancer","volume":"32","author":"Li","year":"2022","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.003055","article-title":"The long noncoding RNA GAS8-AS1 suppresses hepatocarcinogenesis by epigenetically activating the tumor suppressor GAS8","volume":"293","author":"Pan","year":"2018","journal-title":"J Biol Chem"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2019.05.040","article-title":"LncRNA GAS8-AS inhibits colorectal cancer (CRC) cell proliferation by downregulating lncRNA AFAP1-AS1","volume":"710","author":"Zhao","year":"2019","journal-title":"Gene"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-017-1520-1","article-title":"LncRNA GAS8-AS1 inhibits cell proliferation through ATG5-mediated autophagy in papillary thyroid cancer","volume":"59","author":"Qin","year":"2018","journal-title":"Endocrine"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkt1248","article-title":"starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein\u2013RNA interaction networks from large-scale CLIP-Seq data","volume":"42","author":"Li","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052622","article-title":"TNMplot.com: a web tool for the comparison of gene expression in normal, tumor and metastatic tissues","volume":"22","author":"Bartha","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.archoralbio.2022.105428","article-title":"Linc-ROR genetic variants are associated with the advanced disease in oral squamous cell carcinoma","volume":"139","author":"Rose","year":"2022","journal-title":"Arch Oral Biol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"7018","DOI":"10.1038\/s41598-018-25451-3","article-title":"LncRNA OIP5-AS1 is overexpressed in undifferentiated oral tumors and integrated analysis identifies as a downstream effector of stemness-associated transcription factors","volume":"8","author":"Arunkumar","year":"2018","journal-title":"Sci Rep"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/iub.33","article-title":"SWAP-70 is important for invasive phenotypes of mouse embryo fibroblasts transformed by v-Src","volume":"60","author":"Murugan","year":"2008","journal-title":"IUBMB Life"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-20-0242","article-title":"Single nucleotide polymorphisms in matrix metalloproteinase 2 (MMP2) enhance BRAFV600E mutation-mediated oncogenicity and invasiveness of papillary thyroid cancer cells","volume":"28","author":"Murugan","year":"2021","journal-title":"Endocr Relat Cancer"},{"key":"B39","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12859-017-1559-2","article-title":"Reactome pathway analysis: a high-performance in-memory approach","volume":"18","author":"Fabregat","year":"2017","journal-title":"BMC Bioinf"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae1113","article-title":"The STRING database in 2025: protein networks with directionality of regulation","volume":"53","author":"Szklarczyk","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.omtn.2020.09.022","article-title":"ATF2-induced lncRNA GAS8-AS1 promotes autophagy of thyroid cancer cells by targeting the miR-187-3p\/ATG5 and miR-1343-3p\/ATG7 axes","volume":"22","author":"Qin","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S266389","article-title":"LncRNA GAS8-AS1 inhibits ovarian cancer progression through activating Beclin1-mediated autophagy","volume":"13","author":"Fang","year":"2020","journal-title":"Onco Targets Ther"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2128","article-title":"LncRNA GAS8-AS1 downregulates lncRNA NEAT1 to inhibit glioblastoma cell proliferation","volume":"11","author":"Wu","year":"2021","journal-title":"Brain Behav"},{"key":"B44","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13018-020-1550-x","article-title":"lncRNA GAS8-AS1 downregulates lncRNA UCA1 to inhibit osteosarcoma cell migration and invasion","volume":"15","author":"Zha","year":"2020","journal-title":"J Orthop Surg Res"},{"key":"B45","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3892\/ol.2021.13166","article-title":"lncRNA GAS8-AS1 regulates cancer cell proliferation and predicts poor survival of patients with gastric cancer","volume":"23","author":"Li","year":"2022","journal-title":"Oncol Lett"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.28653","article-title":"GAS8 and GAS8-AS1 expression in gastric cancer","volume":"12","author":"Esfandi","year":"2019","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"B47","doi-asserted-by":"publisher","first-page":"104414","DOI":"10.1016\/j.yexmp.2020.104414","article-title":"Expression analysis of growth arrest specific 8 and its anti-sense in breast cancer tissues","volume":"114","author":"Dashti","year":"2020","journal-title":"Exp Mol Pathol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/2645904","article-title":"Plasma lncRNA GAS8-AS1 as a potential biomarker of papillary thyroid carcinoma in Chinese patients","volume":"2017","author":"Zhang","year":"2017","journal-title":"Int J Endocrinol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20181440","article-title":"LncRNA GAS8-AS1 suppresses papillary thyroid carcinoma cell growth through the miR-135b-5p\/CCND2 axis","volume":"39","author":"Chen","year":"2019","journal-title":"Biosci Rep"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1839154\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T05:36:04Z","timestamp":1780896964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1839154\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":49,"alternative-id":["10.3389\/fendo.2026.1839154"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1839154","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"article-number":"1839154"}}